Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C; OPTIPRIM ANRS Study Group.

Lancet Infect Dis. 2015 Apr;15(4):387-96. doi: 10.1016/S1473-3099(15)70021-6. Epub 2015 Feb 18.

PMID:
25701561
2.

Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011.

Schwarcz SK, Vu A, Hsu LC, Hessol NA.

AIDS Patient Care STDS. 2014 Oct;28(10):517-23. doi: 10.1089/apc.2014.0079.

PMID:
25275657
3.

Has the time come to abandon efavirenz for first-line antiretroviral therapy?

Raffi F, Pozniak AL, Wainberg MA.

J Antimicrob Chemother. 2014 Jul;69(7):1742-7. doi: 10.1093/jac/dku058. Epub 2014 Mar 5. Review.

4.

AIDS/HIV infection, comorbid psychiatric illness, and risk for subsequent suicide: a nationwide register linkage study.

Jia CX, Mehlum L, Qin P.

J Clin Psychiatry. 2012 Oct;73(10):1315-21. doi: 10.4088/JCP.12m07814. Epub 2012 Sep 4.

PMID:
23059105
5.

Overdose with HAART: are we managing these patients adequately?

Gabler T, Yudelowitz B, Mahomed A.

S Afr Med J. 2011 Jul 25;101(8):520-1.

PMID:
21920122
6.

Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins.

Lee CL, Dang J, Joo KI, Wang P.

Virus Res. 2011 Sep;160(1-2):340-50. doi: 10.1016/j.virusres.2011.07.010. Epub 2011 Jul 23.

7.

Depression and neurocognitive performance in Portuguese patients infected with HIV.

Bragança M, Palha A.

AIDS Behav. 2011 Nov;15(8):1879-87. doi: 10.1007/s10461-011-9973-3.

PMID:
21598031
8.

Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention.

Michel L, Carrieri MP, Fugon L, Roux P, Aubin HJ, Lert F, Obadia Y, Spire B; VESPA study group.

AIDS Care. 2010 Sep;22(9):1136-45. doi: 10.1080/09540121003605039.

PMID:
20824566
9.

HIV infection and suicide in the era of HAART in England, Wales and Northern Ireland.

Rice BD, Smith RD, Delpech VC.

AIDS. 2010 Jul 17;24(11):1795-7. doi: 10.1097/QAD.0b013e32833af878. No abstract available.

PMID:
20588111
10.

A model of cognitive decline and suicidal ideation in adults aging with HIV.

Vance DE, Ross JA, Moneyham L, Farr KF, Fordham P.

J Neurosci Nurs. 2010 Jun;42(3):150-6.

PMID:
20550075
11.

Development of a nonintegrating Rev-dependent lentiviral vector carrying diphtheria toxin A chain and human TRAF6 to target HIV reservoirs.

Wang Z, Tang Z, Zheng Y, Yu D, Spear M, Iyer SR, Bishop B, Wu Y.

Gene Ther. 2010 Sep;17(9):1063-76. doi: 10.1038/gt.2010.53. Epub 2010 Apr 22.

12.

Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008.

Keiser O, Spoerri A, Brinkhof MW, Hasse B, Gayet-Ageron A, Tissot F, Christen A, Battegay M, Schmid P, Bernasconi E, Egger M; Swiss HIV Cohort Study; Swiss National Cohort.

Am J Psychiatry. 2010 Feb;167(2):143-50. doi: 10.1176/appi.ajp.2009.09050651. Epub 2009 Dec 15.

PMID:
20008942
13.

Current developments in anti-HIV/AIDS gene therapy.

Tsygankov AY.

Curr Opin Investig Drugs. 2009 Feb;10(2):137-49. Review.

PMID:
19197791
14.

Suicidal ideation in adults aging with HIV: neurological and cognitive considerations.

Vance DE, Moneyham L, Farr KF.

J Psychosoc Nurs Ment Health Serv. 2008 Nov;46(11):33-8.

PMID:
19051576
15.

Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).

Michel L, Giorgi R, Villes V, Poizot-Martin I, Dellamonica P, Spire B, Protopopescu C, Carrieri MP.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):96-104. doi: 10.1016/j.drugalcdep.2008.07.007. Epub 2008 Sep 6.

PMID:
18774237
16.

The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.

Ferreros I, Lumbreras B, Hurtado I, Pérez-Hoyos S, Hernández-Aguado I.

Addiction. 2008 Apr;103(4):651-9. doi: 10.1111/j.1360-0443.2008.02135.x.

PMID:
18339110
17.
18.
19.

[HIV infection and comorbidities].

Lacombe K, Pacanowski J.

Rev Prat. 2006 May 15;56(9):995-1004. Review. French.

PMID:
16775980
20.

[Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].

Jacomet C, Lesens O, Villemagne B, Darcha C, Tournilhac O, Henquell C, Cormerais L, Gourdon F, Peigue-Lafeuille H, Travade P, Beytout J, Laurichesse H.

Med Mal Infect. 2006 Mar;36(3):157-62. Epub 2006 Feb 28. French.

PMID:
16503104
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk